A 58-year-old man with type 2 diabetes mellitus and chronic kidney disease (eGFR 22 mL/min/1.73m²) presents to the emergency department with palpitations and muscle weakness. His wife reports he consumed a high-potassium diet (bananas, oranges, tomato juice) over the past 2 days. On examination, blood pressure is 148/92 mmHg, heart rate 102 bpm. Laboratory investigations reveal: serum potassium 7.2 mEq/L, serum creatinine 3.8 mg/dL, pH 7.28, HCO₃⁻ 16 mEq/L. ECG shows peaked T waves and prolonged PR interval. What is the most appropriate immediate intervention?

Explanation

## Clinical Context This patient has **symptomatic hyperkalemia with ECG changes** (peaked T waves, prolonged PR interval) in the setting of CKD, dietary potassium excess, and metabolic acidosis. The combination of severe hyperkalemia (K⁺ 7.2 mEq/L) with cardiac manifestations demands **immediate cardioprotection** followed by potassium removal. ## Management Algorithm for Hyperkalemia ```mermaid flowchart TD A["Serum K+ > 6.5 mEq/L + ECG changes?"]:::decision A -->|Yes| B["Cardiac membrane stabilization"]:::urgent B --> C["IV Calcium gluconate 10%<br/>10-20 mL over 2-5 min"]:::action C --> D["Shift K+ intracellularly"]:::action D --> E["Insulin 10 U IV +<br/>Dextrose 25 g IV"]:::action E --> F["Beta-2 agonist<br/>Albuterol nebulized"]:::action F --> G["Remove K+ from body"]:::action G --> H["Diuretics if euvolemic<br/>Cation exchangers<br/>Dialysis if severe/renal failure"]:::action A -->|No| I["Conservative measures"]:::outcome ``` ## Why IV Calcium Gluconate First? **Key Point:** Calcium does NOT lower serum potassium—it **stabilizes the cardiac myocyte membrane** by raising the threshold potential, preventing dysrhythmias. This is the **only life-saving intervention** in symptomatic hyperkalemia with ECG changes. **High-Yield:** Onset of action is **1–3 minutes**. Effect lasts 30–60 minutes. Must be given BEFORE potassium-shifting agents. ## Sequence of Interventions | Intervention | Mechanism | Onset | Duration | Potassium Lowering | | --- | --- | --- | --- | --- | | **IV Calcium gluconate** | Membrane stabilization | 1–3 min | 30–60 min | 0 (cardioprotection only) | | **Insulin + dextrose** | Shift K⁺ into cells | 10–20 min | 4–6 hrs | ↓ 0.5–1.2 mEq/L | | **Beta-2 agonist** | Shift K⁺ into cells | 30 min | 4–6 hrs | ↓ 0.5–1.0 mEq/L | | **Sodium polystyrene sulfonate** | Fecal K⁺ excretion | 4–24 hrs | Prolonged | ↓ 1–2 mEq/L | | **Diuretics** | Renal K⁺ excretion | 30 min–1 hr | Variable | Limited in CKD | | **Dialysis** | Extracorporeal removal | Immediate | Ongoing | ↓ 1–2 mEq/L per hour | ## Clinical Pearl **Warning:** Do NOT start with sodium polystyrene sulfonate or diuretics alone in symptomatic hyperkalemia with ECG changes. This patient needs **immediate cardioprotection** (calcium) followed by **rapid potassium shift** (insulin + dextrose) and **removal** (dialysis is likely needed given eGFR 22). ## Additional Management Notes **Tip:** This patient also has **metabolic acidosis** (pH 7.28, HCO₃⁻ 16), which worsens hyperkalemia by driving K⁺ out of cells. Sodium bicarbonate may be considered as an adjunct, but it is NOT first-line for acute symptomatic hyperkalemia—calcium gluconate is. **High-Yield:** Given CKD stage 3b and symptomatic hyperkalemia, this patient will likely require **urgent hemodialysis** for definitive potassium removal. [cite:Harrison 21e Ch 280]